Bellevue Group’s Medline Inc MDLN Stock Holding History

Bellevue Group’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.08M	Buy	136,635 +18,915	+16%	+$835K	0.14%	70
2025 Q4	$4.94M	Buy	+117,720	New	+$4.97M	0.09%	76

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

HFCIX

H&F Corporate Investors X San Francisco, California $3.85B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Bellevue Group's MDLN Position: Q1 2026 in Review

Bellevue Group increased its Medline Inc (MDLN) stake by 16% in Q1 2026, buying an estimated $835K and bringing the position to 136,635 shares worth $6.08M. The position accounts for 0.14% of the portfolio, ranked #70.

Bellevue Group first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

Bellevue Group held 136,635 shares of Medline Inc worth $6.08M as of Q1 2026.
Bellevue Group bought 18,915 Medline Inc shares in Q1 2026, an estimated $835K.
Medline Inc made up 0.14% of Bellevue Group's portfolio in Q1 2026, its #70 holding.
Bellevue Group first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.